Mendlein John
- SEC CIK
- 0001238362
No open-market purchases or sales filed in the past year.
Current role at each company
- FATE Fate Therapeutics IncDirectoras of May 30, 2025
- OMGA Omega Therapeutics, Inc.Directoras of Jun 21, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mendlein John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FATE Fate Therapeutics Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2023 (view filing) | Jan 11-13 | 2 days | Mendlein JohnDirector | PPurchase | +124.7K | $5.60 | +$698.1K | +78.9%282.8K after | 2 lots |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Mendlein JohnDirector | SSale | −1.36K | $22.79 | −$31.1K | −0.9%158.1K after | |
| Mar 11, 2022 (view filing) | Mar 10 | 1 day | Mendlein JohnDirector | SSale | −31.6K | $35.02 | −$1.11M | −16.5%159.5K after | 2 lots |